PARKINSON'S DISEASE NEWS

9th February 2011 - New research

INTRANASAL STEM CELLS FOR  PARKINSON'S DISEASE

Rejuvenation Research [2011] February [ahead of print] (Lusine Danielyan, Richard Schäfer, Andreas von Ameln-Mayerhofer, Felix Bernhard, Stephan Verleysdonk, Marine Buadze, Ali Lourhmati, Tim Klopfer, Felix Schaumann, Barbara Schmid, Christoph Koehle, Barbara Proksch, Robert Weissert, Holger M. Reichardt, Jens van den Brandt, Gayane H. Buniatian, Matthias Schwab, Christoph H. Gleiter, William H. Frey) Complete study

Stem cells have been delivered intranasally (via the nose), as a means of trying to treat Parkinson's Disease. Intranasal administration of stem cells to the brain is a proposed alternative to the current surgical procedures, which place stem cells directly in to the brain. Instead of one surgical operation, the ease of intranasal administration opens up the possibility of chronic stem cell treatment, which would increase the number of cells delivered to the brain. Many of the stem cells delivered intranasally survived for at least six months in the brain. The stem cells rapidly migrated to the damaged areas. It is claimed that the method substantially improved motor function in Parkinson's Disease. However, the study was only carried out on rats that did not actually have Parkinson's Disease. For years it had been claimed that stem cell therapy would be able to rid Parkinson's Disease. However, despite stem cell operations now having been carried out around the world, nobody has ever been rid of Parkinson's Disease using stem cell therapy. For more current news go to Parkinson's Disease News.

E-MAIL NOTIFICATION : If you would like to be notified by e-mail when any new research, news reports, new books, or new resources are added to Parkinson's Disease News,  please merely e-mail [email protected] with the message "subscribe".  No form of identity is required.  E-mail addresses are not used for any other purpose.

Parkinson's Disease News details all significant new research, news reports, new books, and new resources concerning Parkinson's Disease and those medical disorders that often coincide with Parkinson's Disease. It is compiled from an analysis of  all newly published research, news reports, new clinical trials, all newly published books, and new web sites. A summary and analysis of the new research are provided,  as well as links to the complete abstracts and news reports